Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.

Clinical trial NCT06736340 · COMPLETED

Trial details

NCT number: NCT06736340
Sponsor: Noucor Health S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2022-11-17
Primary completion: 2025-04-09
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.